OA13.03 Perioperative Durvalumab for Resectable NSCLC (R-NSCLC): Updated Outcomes from the Phase 3 AEGEAN Trial

作者：John V. Heymach, David Harpole, T. Mitsudomi, Janis M. Taube, Shugeng Gao, László Urbán, Jin‐Hyoung Kang, Francesco Orlandi, Jerónimo Rafael Rodríguez‐Cid, Bartomeu Massutí, Leticia Léon Mateos, Giulia Pasello, Quincy S. Chu, Jarosław Kołb-Sielecki, M Nakata, Mike Aperghis, Helen Mann, Tamer M. Fouad, Gary J. Doherty, Martin Reck · 发表于：Journal of Thoracic Oncology · 年份：2024 · DOI：10.1016/j.jtho.2024.09.069 · 被引用次数：25 · 研究领域：Gastric Cancer Management and Outcomes、Radiomics and Machine Learning in Medical Imaging、Colorectal Cancer Surgical Treatments